Insider Stock Trader

Insider buy LYCA

Venrock Healthcare Capital Partners III, L.P. buys $644,711 of Lycia Therapeutics, Inc. (LYCA) as a 10% owner

After the purchase, the filing lists 6,850,237 shares held.

A Form 4 filed on Oct 30 shows Venrock Healthcare Capital Partners III, L.P., a holder of more than 10% of Lycia Therapeutics, Inc., buying 25,004 shares worth $644,711 between Oct 28 and Oct 30, at about $25.78 each.

The purchase was made in the open market, not through an award, an option exercise or a plan. After the trade, the filing lists 6,850,237 shares held.

The trade was reported within two business days, as Section 16 requires.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The purchase
CompanyLycia Therapeutics, Inc. (LYCA)
InsiderVenrock Healthcare Capital Partners III, L.P.
Role10% owner
TransactionOpen-market purchase (code P)
Shares25,004
Average price$25.78
Value$644,711
Trade datesOct 28 to Oct 30, 2026
Filed with the SECOct 30, 2026, 7:25 PM ET
Shares held after6,850,237
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

See the full details of this insider trade

View the Form 4 on SEC.gov

See more large insider purchases · See all insider activity at Lycia Therapeutics, Inc.

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.